rs1190429

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2

The NM_004826.4(ECEL1):​c.1656G>A​(p.Lys552Lys) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0059 in 1,614,200 control chromosomes in the GnomAD database, including 33 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0044 ( 1 hom., cov: 33)
Exomes 𝑓: 0.0061 ( 32 hom. )

Consequence

ECEL1
NM_004826.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 3.29

Publications

3 publications found
Variant links:
Genes affected
ECEL1 (HGNC:3147): (endothelin converting enzyme like 1) This gene encodes a member of the M13 family of endopeptidases. Members of this family are zinc-containing type II integral-membrane proteins that are important regulators of neuropeptide and peptide hormone activity. Mutations in this gene are associated with autosomal recessive distal arthrogryposis, type 5D. This gene has multiple pseudogenes on chromosome 2. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Mar 2014]
ECEL1 Gene-Disease associations (from GenCC):
  • distal arthrogryposis type 5D
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.26).
BP6
Variant 2-232482880-C-T is Benign according to our data. Variant chr2-232482880-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 210908.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=3.29 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0044 (671/152404) while in subpopulation NFE AF = 0.00707 (481/68048). AF 95% confidence interval is 0.00655. There are 1 homozygotes in GnomAd4. There are 301 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 32 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ECEL1NM_004826.4 linkc.1656G>A p.Lys552Lys synonymous_variant Exon 10 of 18 ENST00000304546.6 NP_004817.2
ECEL1NM_001290787.2 linkc.1656G>A p.Lys552Lys synonymous_variant Exon 10 of 18 NP_001277716.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ECEL1ENST00000304546.6 linkc.1656G>A p.Lys552Lys synonymous_variant Exon 10 of 18 1 NM_004826.4 ENSP00000302051.1
ECEL1ENST00000409941.1 linkc.1656G>A p.Lys552Lys synonymous_variant Exon 9 of 17 1 ENSP00000386333.1
ECEL1ENST00000482346.1 linkn.1967G>A non_coding_transcript_exon_variant Exon 9 of 17 2

Frequencies

GnomAD3 genomes
AF:
0.00441
AC:
671
AN:
152286
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00159
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00103
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00707
Gnomad OTH
AF:
0.00621
GnomAD2 exomes
AF:
0.00357
AC:
898
AN:
251410
AF XY:
0.00372
show subpopulations
Gnomad AFR exome
AF:
0.00123
Gnomad AMR exome
AF:
0.00344
Gnomad ASJ exome
AF:
0.0000992
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00176
Gnomad NFE exome
AF:
0.00615
Gnomad OTH exome
AF:
0.00309
GnomAD4 exome
AF:
0.00606
AC:
8852
AN:
1461796
Hom.:
32
Cov.:
33
AF XY:
0.00582
AC XY:
4233
AN XY:
727204
show subpopulations
African (AFR)
AF:
0.00131
AC:
44
AN:
33478
American (AMR)
AF:
0.00391
AC:
175
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.000115
AC:
3
AN:
26136
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.0000232
AC:
2
AN:
86254
European-Finnish (FIN)
AF:
0.00169
AC:
90
AN:
53346
Middle Eastern (MID)
AF:
0.00156
AC:
9
AN:
5768
European-Non Finnish (NFE)
AF:
0.00737
AC:
8193
AN:
1111998
Other (OTH)
AF:
0.00555
AC:
335
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
538
1075
1613
2150
2688
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
302
604
906
1208
1510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00440
AC:
671
AN:
152404
Hom.:
1
Cov.:
33
AF XY:
0.00404
AC XY:
301
AN XY:
74530
show subpopulations
African (AFR)
AF:
0.00159
AC:
66
AN:
41602
American (AMR)
AF:
0.00653
AC:
100
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00103
AC:
11
AN:
10632
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00707
AC:
481
AN:
68048
Other (OTH)
AF:
0.00614
AC:
13
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
38
76
113
151
189
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00522
Hom.:
2
Bravo
AF:
0.00490
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.00682
EpiControl
AF:
0.00711

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:5
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jul 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

ECEL1: BP4, BS2 -

Sep 08, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:2
-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jul 20, 2015
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

ECEL1-related disorder Benign:1
Feb 14, 2023
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.26
CADD
Benign
13
DANN
Benign
0.67
PhyloP100
3.3
PromoterAI
-0.048
Neutral
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1190429; hg19: chr2-233347590; API